Avistone Biotechnology - Startup Rise Asia

Home Tags Avistone Biotechnology

Oncology Company Avistone Biotechnology Secures Approximately USD$140 Mn Series B Funding Round. The funding round was jointly led by SDIC CS Capital and IDG Capital, with participation from Yanchuang Capital and Cathay Capital. Existing shareholder Bain Capital continues to make additional investments.

China based Avistone Biotechnology Secures Approximately USD$140 Mn Series B Funding

Startup Rise - January 5, 2024

Exit mobile version